Bexarotene (targretin®) capsules do not increase the number of circulating CD4+ cells in patients with cutaneous T-cell lymphoma (CTCL) Article uri icon

Overview

authors

  • Inghirami, Giorgio Ga.

publication date

  • December 1, 2000

Identity

Scopus Document Identifier

  • 33748546234

Additional Document Info

volume

  • 96

issue

  • 11 PART II